Financial Gravity Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
Financial Gravity Asset Management's MRNA Position: Q1 2026 in Review
Financial Gravity Asset Management reduced its Moderna (MRNA) stake by 1.9% in Q1 2026, selling an estimated $68.6K and leaving 77,066 shares worth $3.91M. The position accounts for 0.7% of the portfolio, ranked #38.
Financial Gravity Asset Management first reported a position in MRNA in Q2 2021 and has held it in 9 quarters since. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Financial Gravity Asset Management held 77,066 shares of Moderna worth $3.91M as of Q1 2026.
- Financial Gravity Asset Management sold 1,471 Moderna shares in Q1 2026, an estimated $68.6K.
- Moderna made up 0.7% of Financial Gravity Asset Management's portfolio in Q1 2026, its #38 holding.
- Financial Gravity Asset Management first reported a position in Moderna in Q2 2021 and has held it in 9 quarters since.
- 725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.